e-therapeutics is integrating computational power and biology to accelerate the discovery of life-transforming RNAi medicines.
We have developed and validated a powerful computational approach to drug discovery, leveraging our industry-leading expertise in network biology to fully capture and interrogate human disease complexity. Our multi-disciplinary team builds computational models of biological functions to transform the search for new medicines, interventions, mechanisms and genetic support.
Our biology-led in silico laboratory enables rapid hypothesis generation, phenotypic screening and the identification and prioritisation of novel therapeutic targets. We have developed a proprietary GalNAc-siRNA platform technology for highly specific silencing of gene expression in the liver. Harnessing internal target gene discoveries, we are building an in-house pipeline of next-generation RNAi-based medicines.
